|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002045,
umls-concept:C0013203,
umls-concept:C0017431,
umls-concept:C0019704,
umls-concept:C0021469,
umls-concept:C0030705,
umls-concept:C0030946,
umls-concept:C0087111,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C0939237,
umls-concept:C1524063,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2347741,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-1-16
|
|
pubmed:abstractText |
Different approaches using genotypic, pharmacokinetic parameters or combination of both have been recently developed to monitor antiretroviral treatment in HIV-1-infected individuals. Their uses in clinical practice may improve the benefit of protease inhibitor-based salvage therapy while reducing treatment toxicity and emergence of viral resistance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1386-6532
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
131-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17208042-Adult,
pubmed-meshheading:17208042-Aged,
pubmed-meshheading:17208042-Algorithms,
pubmed-meshheading:17208042-Cohort Studies,
pubmed-meshheading:17208042-Drug Resistance, Viral,
pubmed-meshheading:17208042-Female,
pubmed-meshheading:17208042-Genotype,
pubmed-meshheading:17208042-HIV Infections,
pubmed-meshheading:17208042-HIV Protease Inhibitors,
pubmed-meshheading:17208042-HIV-1,
pubmed-meshheading:17208042-Humans,
pubmed-meshheading:17208042-Lopinavir,
pubmed-meshheading:17208042-Male,
pubmed-meshheading:17208042-Middle Aged,
pubmed-meshheading:17208042-Pyrimidinones,
pubmed-meshheading:17208042-Retrospective Studies,
pubmed-meshheading:17208042-Ritonavir,
pubmed-meshheading:17208042-Sensitivity and Specificity,
pubmed-meshheading:17208042-Viral Load
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir-ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
|
|
pubmed:affiliation |
Laboratoire de Virologie, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, 35 033 Rennes, France. anne.maillard@chu-rennes.fr
|
|
pubmed:publicationType |
Journal Article
|
